The EIIS team are excited to announce that Xeolas Pharmaceuticals, the DCU-campus based company has secured investment of €1.3 million from its’ investors. The innovative pharma business has obtained €1.1 million from The Goodbody 2018 EIIS Fund managed by Baker Tilly and Goodbody, and a further €250 thousand from private EIIS investors. The private investors […]
The Manager of the Fund is EIIS Management Limited, a joint venture company owned by Goodbody and Baker Tilly.
Copyright © 2015 EIIS Management | CRO No. 557940. All right reserved.
EIIS Management Limited and Goodbody Stockbrokers, trading as Goodbody, are regulated by the Central Bank of Ireland. Goodbody Stockbrokers is a member of the Irish Stock Exchange and the London Stock Exchange. Goodbody Stockbrokers is a member of the FEXCO group of companies. Baker Tilly Hughes Blake is authorised by the Institute of Chartered Accountants to carry on Investment Business in Ireland.
Website by 
